Telephone sharing button Contact Us linkedin sharing button Share wechat sharing button Share wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Locations

Total estimated capacity for biopharmaceutical production in China, Ireland, the U.S., Germany and Singapore to exceed 430,000 liters by 2024.

United States
Massachusetts
U.S.
107,000sq. ft.
Operational2024
New Jersey
U.S.
66,000sq. ft.
Operational2021
Pennsylvania
U.S.
33,000sq. ft.
OperationalOctober. 2020
Ireland
Dundalk
Ireland
26Hectare campus
Operational2022
WuXi Vaccines
Ireland
$240Million investment
Operational2022
Germany
Leverkusen
Germany
13,000+sq.m. facility
Operations2020
Wuppertal
Germany
30,000+sq.m.
Operations2021
Singapore
Singapore
$60Million investment
Operational2023
China
Shanghai
Waigaoqiao Free Trade Zone
17,748sq. m.
openedOctober 2011
Shanghai
Fengxian District
1.6 millionsq. ft.
Planned2021
Wuxi
15,296sq.m.
OpenedOctober 2012
Suzhou
10,100sq. m.
OpenedDecember 2014
Hangzhou
30,000sq. m.
Operations2021
Chengdu
314,000sq. m.
Planned2023
Shijiazhuang
82,160sq. m.
Planned2022
Hangzhou
50,000sq. m.
Operations2021
Suzhou
11,500sq. m.
Operations2021
Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?